ISPAM Working Group Chair Presentation Book

Analytical Challenges: N b f i l • um er o potent a synt et c  – more than 100 known analogs h 50 l

h i PDE5 i hibi

 n tors:

d d l – more t an  ana ogs reporte as a u terants • Availability of reference standards i f d l • Invent veness o a u terators: – exotic analogs mixtures of analogs – – embedding of adulterants into capsule walls • Complex and variable dietary supplement matrices